Work

Something for Everyone From Low-Risk to High-Risk: 5 Recent Studies to Improve Treatment and Surveillance for All Patients With Squamous Cell Carcinoma of the Head and Neck

Year: 2021

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2021.05.005

Authors: Michelle Mierzwa, Beth M. Beadle, Melvin L.K. Chua, Daniel J. Ma, David J. Thomson, Danielle N. Margalit

Institutions: University of Michigan, Stanford University, National University of Singapore, Duke-NUS Medical School, National Cancer Centre Singapore, Mayo Clinic, University of Manchester, The Christie Hospital, The Christie NHS Foundation Trust, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, Astellas Pharma US, AstraZeneca, Meso Scale Diagnostics, Bayer Fund, Merck Sharp and Dohme, Janssen Pharmaceuticals

OpenAlex ID: W3192732413

FWCI: 0.22

Cites: 42

Cited by: 2

Related to: 10